15h
Corcym Announces First-In-Human Implant of Memo 4D Curve™, Expanding Its Memo Mitral Repair Platform
Corcym announced the first-in-human use of its Memo 4D Curve open-configuration annuloplasty ring for mitral valve repair.
A surgeon with Cleveland Clinic has performed the first-in-human implantation of Corcym's TriMemo technology, a semi-rigid annuloplasty ring built specifically for tricuspid valve repair.
Corcym says Cleveland Clinic doctors performed the first-in-human implantation of TriMemo, a semi-rigid ring designed to repair the tricuspid valve.
TriMemo received FDA clearance in April 2026 and is commercially available in the United States. Corcym will formally introduce the ring to the international cardiac surgery community at the EACTS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results